Status:
COMPLETED
Auditory Neural Function in Implanted Patients With Usher Syndrome
Lead Sponsor:
Ohio State University
Collaborating Sponsors:
National Institute on Deafness and Other Communication Disorders (NIDCD)
Conditions:
Usher Syndrome
Cochlear Implantation
Eligibility:
All Genders
1-85 years
Phase:
NA
Brief Summary
Usher syndrome (USH) causes extensive degeneration in the cochlear nerve (CN), especially in CN fibers innervating the base of the cochlea. As the first step toward developing evidence-based practice ...
Detailed Description
Usher syndrome (USH) is an autosomal recessive disorder characterized by hearing loss, visual impairment, and in some cases, vestibular dysfunction. It is the leading cause of hereditary deaf-blindnes...
Eligibility Criteria
Inclusion
- Minimum of 6 months of listening experience with cochlear implant
- Diagnosed with Usher syndrome or idiopathic hearing loss
Exclusion
- Severe medical comorbidities
- Electrode malposition or migration as determined based on imaging results
Key Trial Info
Start Date :
October 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 11 2025
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT04906135
Start Date
October 1 2021
End Date
July 11 2025
Last Update
July 29 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston children's Hospital
Boston, Massachusetts, United States, 02453
2
Gina Hounam
Columbus, Ohio, United States, 43205-2664
3
The Ohio State University
Columbus, Ohio, United States, 43210
4
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232-8718